次世代シーケンシング市場規模、シェア、動向、2030年までの世界予測

Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2030

次世代シーケンシング市場 - 製品タイプ（消耗品、プラットフォーム、バイオインフォマティクス）、技術（SBS、ナノポア）、ワークフロー（シーケンシング、データ解析）、サービス、用途（創薬、診断、農業） - 2030年までの世界市場予測

出版	MarketsandMarkets
出版年月	2026年01月
ページ数	715
図表数	1131
価格	記載以外のライセンスについてはお問合せください
シングルユーザ	USD 4,950
種別	英文調査報告書
商品番号	SMR-6698

次世代シーケンシング（NGS）市場は、2025年の149億4000万米ドルから2030年には295億3000万米ドルに拡大し、予測期間中の年平均成長率（CAGR）は14.6%に達するとMarketsandMarketsでは予測しています。
腫瘍学、感染症、生殖医療、メタゲノミクス、個別化医療におけるNGSの応用拡大が、市場拡大の主な原動力となっています。同時に、データ分析と解釈のための高度なバイオインフォマティクスツールがNGSの利用を促進し、より幅広いユーザー層がこの技術を採用するのに役立っています。

調査範囲：

本レポートは、NGS市場の成長に影響を与える主要な要因（推進要因、課題、機会、制約など）に関する詳細な情報を網羅しています。主要な業界プレーヤーの詳細な分析を実施し、事業概要、製品・サービスポートフォリオ、製品・サービス発売、提携、パートナーシップ、事業拡大、契約、NGS市場に関連する最近の動向といった主要戦略に関する洞察を提供します。また、NGS市場エコシステムにおける主要プレーヤーおよび新興スタートアップの競合分析も本レポートに含まれています。

レポート購入の主なメリット：

本レポートは、NGS市場全体およびそのサブセグメントの収益に関する最も正確な予測を提供することで、市場リーダーおよび新規参入企業を支援します。また、関係者が競争環境をより深く理解し、事業をより適切に位置づけ、適切な市場参入戦略を策定するための洞察を得るのに役立ちます。本レポートは、関係者が市場の動向を把握し、主要な市場推進要因、制約、機会、課題に関する情報を得ることを可能にします。

本レポートは、以下の点について考察を提供します。

市場の成長に影響を与える主要な推進要因（シーケンスプラットフォームの進歩、シーケンスの臨床応用の拡大、精密医療への需要の高まり、シーケンスコストの低下）、阻害要因（複雑なデータ解析、高額な初期投資）、機会（AIと機械学習の統合、ロングリードシーケンス技術の導入、マルチオミクス統合への注力）、および課題（標準化の問題）の分析。

製品開発／イノベーション：次世代シーケンシング市場における新製品／サービスに関する詳細な分析
市場開発：有望な市場に関する包括的な情報 ― 本レポートは、様々な地域における市場を分析しています。
市場の多様化：次世代シーケンシング市場における新製品・サービス、未開拓地域、最新動向、投資に関する包括的な情報
競合分析：Illumina, Inc.（米国）、Thermo Fisher Scientific Inc.（米国）、F. Hoffmann-La Roche Ltd.（スイス）、Danaher Corporation（米国）、QIAGEN（オランダ）、Agilent Technologies, Inc.（米国）、Revvity（米国）、Eurofins Scientific（ルクセンブルク）、PacBio（米国）、Oxford Nanopore Technologies plc. (英国)、タカラバイオ株式会社 (日本)、BGIグループ (中国)、メルクKGaA (ドイツ)、BD (米国)、10X Genomics (米国)、ニューイングランドバイオラボ (米国)、プロメガコーポレーション (米国)、ノボジェン株式会社 (中国)、LGCリミテッド (英国)、WuXi Biologics (中国)、MGI Tech Co. Ltd. (中国)、Tecan Trading AG (スイス)、Twist Biosciences (米国)、Azenta US, Inc. (米国)、GenScript (米国)、SD Biosensor, Inc. (韓国)、Fulgent Genetics (米国)、Hamilton Company (米国)、Zymo Research Corporation (米国)、NeoGenomics Laboratories (米国)、およびPsomagen (米国)

Report Description

The next-generation sequencing market is expected to reach USD 29.53 billion in 2030, up from USD 14.94 billion in 2025, at a CAGR of 14.6% during the forecast period. The growing application of NGS in oncology, infectious diseases, reproductive health, metagenomics, and personalized medicine is the primary driver of market expansion. Meanwhile, advanced bioinformatics tools for data analysis and interpretation are facilitating the use of NGS, thereby helping a wider user base adopt the technique.

Next-generation Sequencing (NGS) Market – Global Forecast To 2030

“Consumables accounted for the largest share of the product segment in the NGS market in 2024.”

The NGS products market is segmented into consumables, platforms, and bioinformatics tools. In 2024, consumables held the largest share. This segment includes reagents, library preparation kits, sequencing flow cells, and sample preparation kits, which are used in high volumes across many applications. Demand remains robust because consumables are purchased repeatedly, unlike instruments, which are generally one-time investments. The growing use of targeted sequencing and custom panels is also driving demand for specialized, application-specific consumables. Furthermore, an expanding user base and ongoing improvements in sequencing chemistries are drawing more customers toward consumables to simplify their workflows and improve data quality.

“The academic & research institutes segment accounted for the largest share by services end-user segment in the next-generation sequencing market in 2024.”

The next-generation sequencing services market is segmented by end user into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinical laboratories, and other users. In 2024, academic and research institutes held the largest share. This leadership is supported by strong government and private funding for research programs, enabling higher spending on NGS-related needs, including instruments and consumables. Pharmaceutical and biotechnology companies represented the second-largest end-user segment in the market.

Next-generation Sequencing (NGS) Market – Global Forecast To 2030 – region

“The Asia Pacific region will grow at the highest CAGR from 2025 to 2030.”

The Asia Pacific region is estimated to be the fastest-growing segment of the market, owing to large-scale population genomics projects and rising demand for precision medicines. Additionally, the rising prevalence of rare and genetic diseases is attributed to the aging populations in countries such as Japan and China. These factors are supporting the adoption of sequencing technologies in healthcare management and treatment, driving market growth.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 70% and Demand Side 30%
By Designation: Managers – 45% CXOs and Director-level – 30%, and Executives – 25%,
By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%.

List of Companies Profiled in the Report:

Illumina, Inc. (US)
Thermo Fisher Scientific Inc. (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Danaher Corporation (US)
QIAGEN (Netherlands)
Agilent Technologies, Inc. (US)
Revvity (US)
Eurofins Scientific (Luxembourg)
PacBio (US)
Oxford Nanopore Technologies plc. (UK)
Takara Bio Inc. (Japan)
BGI Group (China)
Merck KGaA (Germany)
BD (US)
10X Genomics (US)
New England Biolabs (US)
Promega Corporation (US)
Novogene Co., Ltd. (China)
LGC Limited (UK)
WuXi Biologics (China)
MGI Tech Co. Ltd. (China)
Tecan Trading AG (Switzerland)
Twist Biosciences (US)
Azenta US, Inc. (US)
GenScript (US)
SD Biosensor, Inc. (South Korea)
Fulgent Genetics (US)
Hamilton Company (US)
Zymo Research Corporation (US)
NeoGenomics Laboratories (US)
Psomagen (US)

次世代シーケンシング市場規模、シェア、動向、2030年までの世界予測 - 対象企業

Next-generation Sequencing (NGS) Market – Global Forecast To 2030 – ecosystem

Research Coverage:

The scope of the report covers detailed information on the major factors, such as drivers, challenges, opportunities, and restraints, that influence the growth of the NGS market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, product and service portfolio, key strategies such as product and service launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the NGS market. Competitive analysis of top players and upcoming startups in the NGS market ecosystem is also covered in this report.

Key Benefits of Buying the Report:

The report will help market leaders and new entrants by providing the closest approximations of revenue for the overall NGS market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain insights to better position their business and develop suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following points:

Analysis of key drivers (advancements in sequencing platforms, rising clinical applications of sequencing, growing demand for precision medicine, declining sequencing costs), restraints (complex data analysis, high initial capital investment), opportunities (integration of AI and ML, adoption of long-read sequencing technologies, emphasis on multiomics integration), and challenges (standardization issues) influencing the growth of the market.

Product Development/Innovation: Detailed insights on newly launched products/services of the next-generation sequencing market
Market Development: Comprehensive information about lucrative markets – the report analyzes the market across varied regions
Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the next-generation sequencing market
Competitive Assessment: Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), Revvity (US), Eurofins Scientific (Luxembourg), PacBio (US), Oxford Nanopore Technologies plc. (UK), Takara Bio Inc. (Japan), BGI Group (China), Merck KGaA (Germany), BD (US), 10X Genomics (US), New England Biolabs (US), Promega Corporation (US), Novogene Co., Ltd. (China), LGC Limited (UK), WuXi Biologics (China), MGI Tech Co. Ltd. (China), Tecan Trading AG (Switzerland), Twist Biosciences (US), Azenta US, Inc. (US), GenScript (US), SD Biosensor, Inc. (South Korea), Fulgent Genetics (US), Hamilton Company (US), Zymo Research Corporation (US), NeoGenomics Laboratories (US), and Psomagen (US)

1 INTRODUCTION 58
1.1 STUDY OBJECTIVES 58
1.2 MARKET DEFINITION 58
1.3 STUDY SCOPE 59
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 59
1.3.2 INCLUSIONS & EXCLUSIONS 60
1.4 YEARS CONSIDERED 61
1.5 CURRENCY CONSIDERED 61
1.6 STAKEHOLDERS 62
1.7 SUMMARY OF CHANGES 62
2 EXECUTIVE SUMMARY 63
2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 63
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 64
2.3 DISRUPTIVE TRENDS IN NEXT-GENERATION SEQUENCING MARKET 65
2.4 HIGH-GROWTH SEGMENTS 66
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 67
3 PREMIUM INSIGHTS 68
3.1 NEXT-GENERATION SEQUENCING MARKET OVERVIEW 68
3.2 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET,
BY OFFERING AND COUNTRY 69
3.3 NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY 70
3.4 NEXT-GENERATION SEQUENCING MARKET, BY OFFERING, 2026 VS. 2031 (%) 70
4 MARKET OVERVIEW 71
4.1 INTRODUCTION 71
4.2 MARKET DYNAMICS 71
4.2.1 DRIVERS 72
4.2.1.1 Advancements in sequencing platforms 72
4.2.1.2 Rising clinical applications of sequencing 73
4.2.1.3 Growing demand for precision medicine 73
4.2.1.4 Declining costs of sequencing 73
4.2.2 RESTRAINTS 74
4.2.2.1 Data analysis complexity 74
4.2.2.2 High capital investments and expenses 74
4.2.3 OPPORTUNITIES 74
4.2.3.1 Integration of AI and ML 74
4.2.3.2 Adoption of long-read sequencing technologies 75
4.2.3.3 Emphasis on multiomics integration 75
4.2.4 CHALLENGES 76
4.2.4.1 Standardization issues 76
4.3 UNMET NEEDS AND WHITE SPACES 76
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 76
4.5 STRATEGIC MOVIES BY TIER 1/2/3 PLAYERS 77
5 INDUSTRY TRENDS 78
5.1 PORTER’S FIVE FORCES ANALYSIS 78
5.1.1 INTENSITY OF COMPETITIVE RIVALRY 79
5.1.2 BARGAINING POWER OF SUPPLIERS 79
5.1.3 BARGAINING POWER OF BUYERS 80
5.1.4 THREAT FROM SUBSTITUTES 80
5.1.5 THREAT FROM NEW ENTRANTS 80
5.2 MACROECONOMIC OUTLOOK 80
5.2.1 INTRODUCTION 80
5.2.2 GDP TRENDS AND FORECAST 81
5.2.3 R&D TRENDS IN GLOBAL HEALTHCARE INDUSTRY 81
5.2.4 R&D TRENDS IN GLOBAL BIOTECH INDUSTRY 82
5.3 VALUE CHAIN ANALYSIS 82
5.4 ECOSYSTEM ANALYSIS 83
5.4.1 ROLE OF PLAYERS IN ECOSYSTEM 85
5.5 PRICING ANALYSIS 86
5.5.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER 86
5.5.1.1 Average selling price trend of platforms, by key player 86
5.5.1.2 Average selling price trend of consumables, by key player 87
5.5.2 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER 88
5.5.3 AVERAGE SELLING PRICE TREND, BY REGION 89
5.6 TRADE ANALYSIS 90
5.6.1 IMPORT SCENARIO (HS CODE 382200) 91
5.6.2 EXPORT SCENARIO (HS CODE 382200) 93
5.6.3 IMPORT SCENARIO (HS CODE 902700) 95
5.6.4 EXPORT SCENARIO (HS CODE 902700) 97
5.7 KEY CONFERENCES & EVENTS, 2026–2027 99
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 100
5.9 INVESTMENT & FUNDING SCENARIO 100
5.10 CASE STUDY ANALYSIS 101
5.10.1 COMPREHENSIVE GENOMIC PROFILING TEST EXPANDS PRECISION ONCOLOGY APPLICATIONS 101
5.10.2 ULTRA-SENSITIVE NGS PANEL ENABLES MEASURABLE RESIDUAL DISEASE MONITORING 102
5.10.3 NGS-BASED MYELOID FUSION PANEL ENHANCES HEMATOLOGIC MALIGNANCY RESEARCH 102
5.11 IMPACT OF 2025 US TARIFF ON NEXT-GENERATION SEQUENCING MARKET 102
5.11.1 INTRODUCTION 102
5.11.2 KEY TARIFF RATES 103
5.11.3 PRICE IMPACT ANALYSIS 104
5.11.4 IMPACT ON COUNTRY/REGION 104
5.11.4.1 US 104
5.11.4.2 Europe 105
5.11.4.3 Asia Pacific 105
5.11.5 IMPACT ON END-USE INDUSTRIES 105
5.11.5.1 Pharmaceutical & biotechnology companies 106
5.11.5.2 CROs and academic & research institutes 106
5.11.5.3 Hospitals, diagnostic laboratories, and clinics 106
6 CUSTOMER LANDSCAPE & BUYER BEHAVIOUR 107
6.1 DECISION-MAKING PROCESS 107
6.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 107
6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 107
6.2.2 KEY BUYING CRITERIA FOR NGS PRODUCTS, BY END USER 108
6.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 109
6.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 109
7 SUSTAINABILITY AND REGULATORY LANDSCAPE 111
7.1 REGIONAL REGULATIONS AND COMPLIANCE 111
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
7.1.2 INDUSTRY STANDARDS 113
7.1.2.1 North America 113
7.1.2.2 Europe 114
7.1.2.3 Asia Pacific 114
7.1.2.4 Rest of the world 115
7.2 SUSTAINABILITY INITIATIVES 115
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 115
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 116
8 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 118
8.1 TECHNOLOGY ANALYSIS 118
8.1.1 KEY TECHNOLOGIES 118
8.1.1.1 Sequencing by synthesis 118
8.1.1.2 Ion semiconductor sequencing 118
8.1.1.3 Nanopore sequencing 119
8.1.1.4 Single-molecule real-time sequencing (SMRT) 119
8.1.2 COMPLEMENTARY TECHNOLOGIES 120
8.1.2.1 Automated sample preparation systems 120
8.1.2.2 Bioinformatics and data analysis platforms 120
8.1.2.3 CRISPR-based targeted sequencing 121
8.1.2.4 Multiplex PCR 121
8.1.3 ADJACENT TECHNOLOGIES 121
8.1.3.1 Single-cell sequencing technology 121
8.1.3.2 Multiomics integration 122
8.1.3.3 Spatial genomics and transcriptomics 122
8.1.3.4 Gene editing technologies 122
8.2 TECHNOLOGY ROADMAP 123
8.3 PATENT ANALYSIS 123
8.3.1 METHODOLOGY 123
8.3.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE 124
8.3.3 LIST OF KEY PATENTS 125
8.4 FUTURE APPLICATIONS 125
8.5 IMPACT OF AI/GEN AI ON NEXT-GENERATION SEQUENCING MARKET 126
8.5.1 TOP USE CASES AND MARKET POTENTIAL 127
8.5.2 BEST PRACTICES IN AI-ENABLED NGS WORKFLOWS 128
8.5.3 CASE STUDIES OF AI IMPLEMENTATION IN NEXT-GENERATION SEQUENCING MARKET 128
8.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 128
8.5.5 CLIENTS’ READINESS TO ADOPT AI-INTEGRATED SEQUENCING SOLUTIONS IN NEXT-GENERATION SEQUENCING MARKET 129
9 NEXT-GENERATION SEQUENCING MARKET, BY OFFERING 130
9.1 INTRODUCTION 131
9.2 PRODUCTS 131
9.2.1 DEMAND FOR CONSUMABLES AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET 131
9.3 SERVICES 134
9.3.1 SHIFT TOWARD SERVICE-BASED MODELS TO DRIVE MARKET 134
10 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY TYPE 138
10.1 INTRODUCTION 139
10.2 CONSUMABLES 139
10.2.1 LIBRARY PREPARATION KITS & REAGENTS 143
10.2.1.1 Strong demand and growing applications to ensure market growth 143
10.2.2 SEQUENCING KITS & REAGENTS 147
10.2.2.1 Focus on technological advancements to support market growth 147
10.2.3 OTHER CONSUMABLES 151

10.3 PLATFORMS 154
10.3.1 SEQUENCING PLATFORMS 157
10.3.1.1 Need for advanced technologies to decode genetic information to drive market 157
10.3.1.2 Illumina 160
10.3.1.2.1 NovaSeq Series (X/X Plus) 161
10.3.1.2.1.1 Next-generation ultra-high throughput sequencing to enable large-scale genomics 161
10.3.1.2.2 MiSeq/MiSeq i100 162
10.3.1.2.2.1 Compact sequencing platforms to enable rapid and targeted genomic analysis 162
10.3.1.2.3 NextSeq 1k/2K and 550 163
10.3.1.2.3.1 Mid-throughput sequencing systems to support diverse research and clinical applications 163
10.3.1.2.4 NovaSeq 6000 164
10.3.1.2.4.1 High-throughput sequencing platform to enable large-scale genomic studies 164
10.3.1.3 Thermo Fisher Scientific 165
10.3.1.4 PacBio 166
10.3.1.4.1 Revio 167
10.3.1.4.1.1 High-throughput long-read sequencing to support market growth 167
10.3.1.4.2 Sequel II/IIe 168
10.3.1.4.2.1 High-accuracy, long-read sequencing to support market growth 168
10.3.1.4.3 Vega Seq 169
10.3.1.4.3.1 Benchtop long-read sequencing platform to support market growth 169
10.3.1.5 Oxford Nanopore Technologies 170
10.3.1.6 Other sequencing platforms 170
10.3.2 LIBRARY PREPARATION PLATFORMS 171
10.3.2.1 Rising demand for sequencing in clinical applications to drive market 171
10.4 BIOINFORMATICS TOOLS 174
10.4.1 DATA ANALYSIS SOFTWARE & WORKBENCHES 178
10.4.1.1 Demand for genome analysis in clinical diagnostics to support market growth 178
10.4.2 DATA VISUALIZATION TOOLS 182
10.4.2.1 Rising demand for sequencing-based research to support market growth 182
10.4.3 OTHER BIOINFORMATICS TOOLS 185
11 NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TECHNOLOGY 188
11.1 INTRODUCTION 189
11.2 SEQUENCING BY SYNTHESIS 190
11.2.1 HIGH, RAPID PRODUCTION OF BASE PAIRS TO SUPPORT ADOPTION 190

11.3 ION SEMICONDUCTOR SEQUENCING 194
11.3.1 SIMPLER WORKFLOW AND COST-EFFECTIVENESS TO SUPPORT MARKET GROWTH 194
11.4 SMRT SEQUENCING 198
11.4.1 FOCUS ON RAPID RESULTS AND LOWER SEQUENCING COSTS TO DRIVE MARKET 198
11.5 NANOPORE SEQUENCING 201
11.5.1 EMPHASIS ON DIRECT RNA SEQUENCING CAPABILITIES TO PROPEL DEMAND 201
11.6 OTHER SEQUENCING TECHNOLOGIES 205
12 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY WORKFLOW 209
12.1 INTRODUCTION 210
12.2 SEQUENCING 210
12.2.1 ABILITY TO ADDRESS COMPLEX GENOMIC REGIONS AND RESOLVE STRUCTURAL VARIATIONS TO DRIVE MARKET 210
12.3 PRESEQUENCING 214
12.3.1 INCREASED RESEARCH AND SUPPLY AGREEMENTS BETWEEN INDUSTRY PARTICIPANTS TO DRIVE MARKET 214
12.4 DATA ANALYSIS 218
12.4.1 RISE OF IN-HOUSE INSTALLATION OF BIOINFORMATICS INFRASTRUCTURE TO DRIVE MARKET 218
13 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY END USER 222
13.1 INTRODUCTION 223
13.2 ACADEMIC & RESEARCH INSTITUTES 223
13.2.1 RISING RESEARCH INTENSITY FOR GENOME RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH 223
13.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 227
13.3.1 RISING DEMAND FOR COMPREHENSIVE SEQUENCING DATA IN GENETIC RESEARCH TO DRIVE MARKET 227
13.4 CLINICAL & DIAGNOSTIC LABORATORIES 231
13.4.1 INCREASED APPLICATIONS IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE MARKET GROWTH 231
13.5 OTHER END USERS 234
14 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE 238
14.1 INTRODUCTION 239
14.2 SEQUENCING SERVICES 239
14.2.1 EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS 243
14.2.1.1 Advancements in target enrichment technologies to drive market 243
14.2.2 RNA SEQUENCING SERVICES 247
14.2.2.1 Launch of RNA services and availability of diverse RNA bioinformatics tools to drive market 247

14.2.3 DE NOVO SEQUENCING SERVICES 250
14.2.3.1 Need for more accurate and faster characterization than traditional methods to drive market 250
14.2.4 CHIP SEQUENCING SERVICES 253
14.2.4.1 Surge in demand from academic and research institutes to drive market 253
14.2.5 WHOLE-GENOME SEQUENCING SERVICES 257
14.2.5.1 Technological advancements in next-generation sequencing products to drive market 257
14.2.6 METHYL SEQUENCING SERVICES 260
14.2.6.1 Large-scale adoption in cancer research to drive market 260
14.2.7 OTHER SEQUENCING SERVICES 264
14.3 PRESEQUENCING SERVICES 267
14.3.1 LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES 270
14.3.1.1 Development of advanced library preparation solutions to drive market 270
14.3.2 SAMPLE PREPARATION SERVICES 274
14.3.2.1 Applicability in oncology, infectious diseases, metagenomics, and epigenetics to drive market 274
14.3.3 QUALITY CONTROL SERVICES 277
14.3.3.1 Growing research activities using next-generation sequencing technology to drive market 277
14.4 BIOINFORMATICS & DATA ANALYSIS SERVICES 280
14.4.1 DATA ANALYSIS SERVICES 284
14.4.1.1 Increasing demand for precision and speed in genomics for clinical diagnosis to drive market 284
14.4.2 DATA VISUALIZATION & INTERPRETATION SERVICES 288
14.4.2.1 Rising demand for sequencing-based research to drive market 288
14.4.3 DATA STORAGE & MANAGEMENT SERVICES 291
14.4.3.1 Need for effective data management to drive market 291
14.5 NGS PLATFORM SERVICES 294
14.5.1 COMPLIANCE WITH STRINGENT QUALITY AND OPERATIONAL REQUIREMENTS TO DRIVE MARKET 294
15 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY WORKFLOW 298
15.1 INTRODUCTION 299
15.2 SEQUENCING 299
15.2.1 RISING DEMAND FOR SEQUENCING SERVICES AND APPLICATIONS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH 299
15.3 PRESEQUENCING SERVICES 303
15.3.1 CUSTOM DEVELOPMENT OF SAMPLES FOR SEQUENCING TO BOOST MARKET GROWTH 303
15.4 DATA ANALYSIS SERVICES 306
15.4.1 RISING DEMAND FOR ADVANCED RESEARCH TO DRIVE MARKET 306
16 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER 310
16.1 INTRODUCTION 311
16.2 ACADEMIC & RESEARCH INSTITUTES 311
16.2.1 GROWING RESEARCH INTENSITY TO SUPPORT MARKET GROWTH 311
16.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 315
16.3.1 RISING DEMAND FOR COMPREHENSIVE GENETIC DATA TO DRIVE GROWTH 315
16.4 HOSPITALS & CLINICAL LABORATORIES 318
16.4.1 INCREASED APPLICATION IN NGS IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE GROWTH 318
16.5 OTHER END USERS 322
17 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION 326
17.1 INTRODUCTION 327
17.2 DIAGNOSTICS 327
17.2.1 CANCER DIAGNOSTICS 331
17.2.1.1 Rising demand for targeted therapies to drive market 331
17.2.2 INFECTIOUS DISEASE DIAGNOSTICS 335
17.2.2.1 Rising demand for comprehensive genomic data in clinical diagnostics to propel growth 335
17.2.3 REPRODUCTIVE HEALTH DIAGNOSTICS 338
17.2.3.1 Focus on genetic disease diagnostics to drive growth 338
17.2.4 OTHER DIAGNOSTIC APPLICATIONS 342
17.3 DRUG DISCOVERY & DEVELOPMENT 345
17.3.1 PHARMACOGENOMICS 348
17.3.1.1 Rising use of NGS for understanding genomic variants in humans to drive growth 348
17.3.2 OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS 352
17.4 AGRICULTURE & ANIMAL RESEARCH 355
17.4.1 EMPHASIS ON IMPROVING CROP PRODUCTIVITY TO DRIVE ADOPTION OF NGS 355
17.5 OTHER APPLICATIONS 358
18 NEXT-GENERATION SEQUENCING MARKET, BY REGION 362
18.1 INTRODUCTION 363
18.2 NORTH AMERICA 363
18.2.1 US 372
18.2.1.1 Rapid growth and advancements to lead market 372
18.2.2 CANADA 379
18.2.2.1 Increasing government initiatives in sequencing research to boost market growth 379
18.3 EUROPE 386
18.3.1 GERMANY 393
18.3.1.1 Adoption of advanced sequencing technologies to drive market 393

18.3.2 UK 400
18.3.2.1 Strategic initiatives and funding for genomics research to support market growth 400
18.3.3 FRANCE 407
18.3.3.1 Increasing government investment in genomics research to drive growth 407
18.3.4 ITALY 414
18.3.4.1 Favorable funding scenario to drive adoption of advanced sequencing technology 414
18.3.5 SPAIN 421
18.3.5.1 Growing focus on advancements in personalized medicine to support market growth 421
18.3.6 NETHERLANDS 428
18.3.6.1 Well-established research infrastructure to sustain demand for NGS 428
18.3.7 REST OF EUROPE 435
18.4 ASIA PACIFIC 443
18.4.1 CHINA 451
18.4.1.1 Favorable regulatory reforms to drive market 451
18.4.2 JAPAN 458
18.4.2.1 Rising number of collaborations in NGS to drive market 458
18.4.3 INDIA 465
18.4.3.1 Government and private initiatives for genomics projects to propel market 465
18.4.4 AUSTRALIA 472
18.4.4.1 Increased genetic research in Australia to support market growth 472
18.4.5 SOUTH KOREA 479
18.4.5.1 Demand for advanced sequencing technologies to support market 479
18.4.6 REST OF ASIA PACIFIC 486
18.5 LATIN AMERICA 494
18.5.1 BRAZIL 501
18.5.1.1 Increased government investments in genomics advancements to drive market 501
18.5.2 MEXICO 507
18.5.2.1 Rising demand for chronic disease treatment to support growth 507
18.5.3 REST OF LATIN AMERICA 514
18.6 MIDDLE EAST 522
18.6.1 GCC COUNTRIES 529
18.6.1.1 Saudi Arabia 536
18.6.1.1.1 Growing healthcare expenditure in Saudi Arabia to boost market growth 536
18.6.1.2 UAE 543
18.6.1.2.1 Collaborations to advance genome sequencing and market growth 543
18.6.1.3 Rest of GCC countries 549
18.6.2 REST OF MIDDLE EAST 557
18.7 AFRICA 565
18.7.1 GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET 565
19 COMPETITIVE LANDSCAPE 574
19.1 INTRODUCTION 574
19.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 574
19.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NGS MARKET 574
19.3 REVENUE ANALYSIS, 2021–2025 576
19.4 MARKET SHARE ANALYSIS, 2025 577
19.5 BRAND/PRODUCT COMPARISON 580
19.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 581
19.6.1 STARS 581
19.6.2 EMERGING LEADERS 581
19.6.3 PERVASIVE PLAYERS 581
19.6.4 PARTICIPANTS 581
19.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 583
19.6.5.1 Company footprint 583
19.6.5.2 Region footprint 584
19.6.5.3 Offering footprint 585
19.6.5.4 Application footprint 586
19.6.5.5 Technology footprint 587
19.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 588
19.7.1 PROGRESSIVE COMPANIES 588
19.7.2 RESPONSIVE COMPANIES 588
19.7.3 DYNAMIC COMPANIES 588
19.7.4 STARTING BLOCKS 589
19.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 590
19.7.5.1 Detailed list of key startups/SMEs 590
19.7.5.2 Competitive benchmarking of startups/SMEs 591
19.8 COMPANY VALUATION & FINANCIAL METRICS 592
19.8.1 COMPANY VALUATION 592
19.8.2 FINANCIAL METRICS 592
19.9 COMPETITIVE SCENARIO 593
19.9.1 PRODUCT LAUNCHES 593
19.9.2 DEALS 594
19.9.3 EXPANSIONS 595

20 COMPANY PROFILES 596
20.1 KEY PLAYERS 596
20.1.1 ILLUMINA, INC. 596
20.1.1.1 Business overview 596
20.1.1.2 Products/Services offered 597
20.1.1.3 Recent developments 600
20.1.1.3.1 Product launches 600
20.1.1.3.2 Deals 601
20.1.1.4 MnM view 602
20.1.1.4.1 Key strengths 602
20.1.1.4.2 Strategic choices 602
20.1.1.4.3 Weaknesses and competitive threats 602
20.1.2 THERMO FISHER SCIENTIFIC INC. 603
20.1.2.1 Business overview 603
20.1.2.2 Products/Services offered 604
20.1.2.3 Recent developments 607
20.1.2.3.1 Product launches 607
20.1.2.3.2 Deals 608
20.1.2.3.3 Expansions 609
20.1.2.4 MnM view 609
20.1.2.4.1 Key strengths 609
20.1.2.4.2 Strategic choices 609
20.1.2.4.3 Weaknesses and competitive threats 609
20.1.3 AGILENT TECHNOLOGIES, INC. 610
20.1.3.1 Business overview 610
20.1.3.2 Products/Services offered 611
20.1.3.3 Recent developments 613
20.1.3.3.1 Deals 613
20.1.3.3.2 Expansions 614
20.1.3.4 MnM view 614
20.1.3.4.1 Key strengths 614
20.1.3.4.2 Strategic choices 614
20.1.3.4.3 Weaknesses and competitive threats 614
20.1.4 F. HOFFMANN-LA ROCHE LTD. 615
20.1.4.1 Business overview 615
20.1.4.2 Products/Services offered 616
20.1.4.3 Recent developments 618
20.1.4.3.1 Product launches 618
20.1.4.3.2 Deals 618
20.1.4.3.3 Other developments 619
20.1.4.4 MnM view 619
20.1.4.4.1 Key strengths 619
20.1.4.4.2 Strategic choices 619
20.1.4.4.3 Weaknesses and competitive threats 619
20.1.5 QIAGEN 620
20.1.5.1 Business overview 620
20.1.5.2 Products/services offered 621
20.1.5.3 Recent developments 623
20.1.5.3.1 Deals 624
20.1.5.3.2 Expansions 625
20.1.5.4 MnM view 626
20.1.5.4.1 Key strengths 626
20.1.5.4.2 Strategic choices 626
20.1.5.4.3 Weaknesses and competitive threats 626
20.1.6 DANAHER CORPORATION 627
20.1.6.1 Business overview 627
20.1.6.2 Products/services offered 628
20.1.6.3 Recent developments 630
20.1.6.3.1 Product launches 630
20.1.6.3.2 Deals 631
20.1.6.3.3 Expansions 631
20.1.7 REVVITY 632
20.1.7.1 Business overview 632
20.1.7.2 Products/Services offered 633
20.1.7.3 Recent developments 635
20.1.7.3.1 Product launches 635
20.1.7.3.2 Deals 635
20.1.7.3.3 Expansions 636
20.1.8 EUROFINS SCIENTIFIC 637
20.1.8.1 Business overview 637
20.1.8.2 Products/services offered 638
20.1.8.3 Recent developments 638
20.1.8.3.1 Deals 638
20.1.9 PACBIO 639
20.1.9.1 Business overview 639
20.1.9.2 Products/Services offered 640
20.1.9.3 Recent developments 643
20.1.9.3.1 Product launches 643
20.1.9.3.2 Deals 643
20.1.9.3.3 Expansions 644
20.1.10 OXFORD NANOPORE TECHNOLOGIES PLC 645
20.1.10.1 Business overview 645
20.1.10.2 Products/Services offered 646
20.1.10.3 Recent developments 648
20.1.10.3.1 Deals 648
20.1.10.3.2 Expansions 649
20.1.11 TAKARA BIO INC. 650
20.1.11.1 Business overview 650
20.1.11.2 Products/Services offered 651
20.1.11.3 Recent developments 653
20.1.11.3.1 Deals 653
20.1.12 BGI GROUP 654
20.1.12.1 Business overview 654
20.1.12.2 Products/Services offered 654
20.1.13 BD 658
20.1.13.1 Business overview 658
20.1.13.2 Products/Services offered 659
20.1.13.3 Recent developments 660
20.1.13.3.1 Product launches 660
20.1.14 10X GENOMICS 661
20.1.14.1 Business overview 661
20.1.14.2 Products/Services offered 662
20.1.15 PROMEGA CORPORATION 665
20.1.15.1 Business overview 665
20.1.15.2 Products/Services offered 665
20.1.16 LGC LIMITED 666
20.1.16.1 Business overview 666
20.1.16.2 Products/Services offered 667
20.1.16.3 Recent developments 668
20.1.16.3.1 Deals 668
20.1.17 WUXI BIOLOGICS 669
20.1.17.1 Business overview 669
20.1.17.2 Products/Services offered 670
20.1.18 TECAN TRADING AG 671
20.1.18.1 Business overview 671
20.1.18.2 Products/Services offered 672
20.1.18.3 Recent developments 673
20.1.18.3.1 Deals 673
20.1.19 TWIST BIOSCIENCE 674
20.1.19.1 Business overview 674
20.1.19.2 Products/Services offered 675
20.1.19.3 Recent developments 676
20.1.19.3.1 Product launches 676
20.1.19.3.2 Deals 677

20.1.20 AZENTA US INC. 678
20.1.20.1 Business overview 678
20.1.20.2 Products/Services offered 679
20.1.20.3 Recent developments 680
20.1.20.3.1 Deals 680
20.2 OTHER PLAYERS 681
20.2.1 MGI TECH CO. LTD. 681
20.2.2 NOVOGENE CO., LTD. 683
20.2.3 NEW ENGLAND BIOLABS 684
20.2.4 GENSCRIPT 685
20.2.5 PSOMAGEN 685
20.2.6 ZYMO RESEARCH CORPORATION 686
20.2.7 HAMILTON COMPANY 687
20.2.8 NEOGENOMICS LABORATORIES 688
20.2.9 FULGENT GENETICS 689
20.2.10 SD BIOSENSOR, INC. 690
21 RESEARCH METHODOLOGY 691
21.1 RESEARCH DATA 691
21.1.1 SECONDARY DATA 691
21.1.1.1 Key data from secondary sources 691
21.1.2 PRIMARY DATA 692
21.1.2.1 Key data from primary sources 692
21.1.2.2 Key primary participants 693
21.1.2.3 Breakdown of primary interviews 693
21.1.2.4 Key industry insights 694
21.2 MARKET SIZE ESTIMATION 695
21.2.1 GLOBAL NEXT-GENERATION SEQUENCING MARKET ESTIMATION, 2025 695
21.2.2 SEGMENTAL MARKET SIZE ESTIMATION 697
21.3 MARKET GROWTH RATE PROJECTIONS 699
21.4 DATA TRIANGULATION 701
21.5 FACTOR ANALYSIS 702
21.6 RESEARCH ASSUMPTIONS 702
21.7 RESEARCH LIMITATIONS AND RISK ASSESSMENT 703
22 APPENDIX 705
22.1 DISCUSSION GUIDE 705
22.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 711
22.3 CUSTOMIZATION OPTIONS 713
22.4 RELATED REPORTS 713
22.5 AUTHOR DETAILS 714

LIST OF TABLES

TABLE 1 NEXT-GENERATION SEQUENCING MARKET: INCLUSIONS & EXCLUSIONS 60
TABLE 2 IMPACT OF MARKET DYNAMICS 72
TABLE 3 NEXT-GENERATION SEQUENCING MARKET: PORTER’S FIVE FORCES 78
TABLE 4 NEXT-GENERATION SEQUENCING MARKET: ROLE OF PLAYERS IN ECOSYSTEM 85
TABLE 5 AVERAGE SELLING PRICE TREND OF PLATFORMS, BY KEY PLAYER,
2023–2025 (USD) 86
TABLE 6 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER,
2023–2025 (USD) 87
TABLE 7 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2025 (USD) 88
TABLE 8 AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 (USD) 89
TABLE 9 IMPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 91
TABLE 10 IMPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (TONS) 92
TABLE 11 EXPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 93
TABLE 12 EXPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (TONS) 94
TABLE 13 IMPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 95
TABLE 14 IMPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (TONS) 96
TABLE 15 EXPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 97
TABLE 16 EXPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (TONS) 98
TABLE 17 NEXT-GENERATION SEQUENCING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026–MARCH 2027 99
TABLE 18 RECIPROCAL TARIFF RATES ADJUSTED BY US 103
TABLE 19 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES 104
TABLE 20 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE 108
TABLE 21 KEY BUYING CRITERIA FOR PRODUCTS, BY END USER 108
TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112
TABLE 25 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113
TABLE 26 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015–2025 124
TABLE 27 KEY PATENTS, 2023–2025 125
TABLE 28 CASE STUDIES OF AI IMPLEMENTATION IN NEXT-GENERATION SEQUENCING MARKET 128
TABLE 29 CLIENT’S READINESS TO ADOPT AI-INTEGRATED SEQUENCING SOLUTIONS IN NEXT-GENERATION SEQUENCING MARKET 129
TABLE 30 NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 131
TABLE 31 NGS PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 132
TABLE 32 NORTH AMERICA: NGS PRODUCTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 132
TABLE 33 EUROPE: NGS PRODUCTS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 132
TABLE 34 ASIA PACIFIC: NGS PRODUCTS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 133
TABLE 35 LATIN AMERICA: NGS PRODUCTS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 133
TABLE 36 MIDDLE EAST: NGS PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 133
TABLE 37 GCC COUNTRIES: NGS PRODUCTS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 134
TABLE 38 NGS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 135
TABLE 39 NORTH AMERICA: NGS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 135
TABLE 40 EUROPE: NGS SERVICES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 135
TABLE 41 ASIA PACIFIC: NGS SERVICES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 136
TABLE 42 LATIN AMERICA: NGS SERVICES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 136
TABLE 43 MIDDLE EAST: NGS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 136
TABLE 44 GCC COUNTRIES: NGS SERVICES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 137
TABLE 45 NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 139
TABLE 46 NGS CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 140
TABLE 47 NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 140
TABLE 48 EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 141
TABLE 49 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 141
TABLE 50 LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 142
TABLE 51 MIDDLE EAST: NGS CONSUMABLES MARKET, BY REGION,
2024–2031 (USD MILLION) 142
TABLE 52 GCC COUNTRIES: NGS CONSUMABLES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 142
TABLE 53 NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 143
TABLE 54 LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 144
TABLE 55 NORTH AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 145
TABLE 56 EUROPE: LIBRARY PREPARATION KITS & REAGENTS MARKET,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 145
TABLE 57 ASIA PACIFIC: LIBRARY PREPARATION KITS & REAGENTS MARKET,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 146
TABLE 58 LATIN AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 146
TABLE 59 MIDDLE EAST: LIBRARY PREPARATION KITS & REAGENTS MARKET,
BY REGION/REGION, 2024–2031 (USD MILLION) 146
TABLE 60 GCC COUNTRIES: LIBRARY PREPARATION KITS & REAGENTS MARKET,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 147
TABLE 61 SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 148
TABLE 62 NORTH AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 148
TABLE 63 EUROPE: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 149
TABLE 64 ASIA PACIFIC: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 149
TABLE 65 LATIN AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 150
TABLE 66 MIDDLE EAST: SEQUENCING KITS & REAGENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 150
TABLE 67 GCC COUNTRIES: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 150
TABLE 68 OTHER CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 151
TABLE 69 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 151
TABLE 70 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 152
TABLE 71 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 152
TABLE 72 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 153
TABLE 73 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY REGION,
2024–2031 (USD MILLION) 153
TABLE 74 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 153
TABLE 75 NGS PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION) 154
TABLE 76 NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 154
TABLE 77 EUROPE: NGS PLATFORMS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 155
TABLE 78 ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 155
TABLE 79 LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 156
TABLE 80 MIDDLE EAST: NGS PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION) 156
TABLE 81 GCC COUNTRIES: NGS PLATFORMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 156
TABLE 82 NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 157
TABLE 83 SEQUENCING PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION) 157
TABLE 84 NORTH AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 158
TABLE 85 EUROPE: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 158
TABLE 86 ASIA PACIFIC: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 159
TABLE 87 LATIN AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 159
TABLE 88 MIDDLE EAST: SEQUENCING PLATFORMS MARKET, BY REGION,
2024–2031 (USD MILLION) 159
TABLE 89 GCC COUNTRIES: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 160
TABLE 90 SEQUENCING PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 160
TABLE 91 ILLUMINA SEQUENCING PLATFORMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 161
TABLE 92 ILLUMINA SEQUENCING PLATFORMS MARKET, BY REGION,
2024–2031 (USD MILLION) 161
TABLE 93 NOVASEQ (X/X PLUS) SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 162
TABLE 94 MISEQ/MISEQ I100 SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 163
TABLE 95 NEXTSEQ 1K/2K AND 550 SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 164
TABLE 96 NOVASEQ 6000 SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 165
TABLE 97 THERMO FISHER SCIENTIFIC SEQUENCING PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION) 166
TABLE 98 PACBIO SEQUENCING PLATFORMS MARKET, BY REGION,
2024–2031 (USD MILLION) 166
TABLE 99 OXFORD NANOPORE TECHNOLOGIES SEQUENCING PLATFORMS MARKET,
BY REGION, 2024–2031 (USD MILLION) 170
TABLE 100 LIBRARY PREPARATION PLATFORMS MARKET, BY REGION,
2024–2031 (USD MILLION) 171
TABLE 101 NORTH AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 172
TABLE 102 EUROPE: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 172
TABLE 103 ASIA PACIFIC: LIBRARY PREPARATION PLATFORMS MARKET,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 173
TABLE 104 LATIN AMERICA: LIBRARY PREPARATION PLATFORMS MARKET,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 173
TABLE 105 MIDDLE EAST: LIBRARY PREPARATION PLATFORMS MARKET, BY REGION/REGION, 2024–2031 (USD MILLION) 173
TABLE 106 GCC COUNTRIES: LIBRARY PREPARATION PLATFORMS MARKET,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 174
TABLE 107 NGS BIOINFORMATICS TOOLS MARKET, BY REGION, 2024–2031 (USD MILLION) 175
TABLE 108 NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 175
TABLE 109 EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 176
TABLE 110 ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 176
TABLE 111 LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 177
TABLE 112 MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY REGION,
2024–2031 (USD MILLION) 177
TABLE 113 GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 177
TABLE 114 NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 177
TABLE 115 DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION,
2024–2031 (USD MILLION) 179
TABLE 116 NORTH AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 117 EUROPE: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 180
TABLE 118 ASIA PACIFIC: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 180
TABLE 119 LATIN AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 181
TABLE 120 MIDDLE EAST: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,
BY REGION, 2024–2031 (USD MILLION) 181
TABLE 121 GCC COUNTRIES: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 181
TABLE 122 DATA VISUALIZATION TOOLS MARKET, BY REGION, 2024–2031 (USD MILLION) 182
TABLE 123 NORTH AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 182
TABLE 124 EUROPE: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 183
TABLE 125 ASIA PACIFIC: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 183
TABLE 126 LATIN AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 184
TABLE 127 MIDDLE EAST: DATA VISUALIZATION TOOLS MARKET, BY REGION,
2024–2031 (USD MILLION) 184
TABLE 128 GCC COUNTRIES: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 184
TABLE 129 OTHER BIOINFORMATICS TOOLS MARKET, BY REGION, 2024–2031 (USD MILLION) 185
TABLE 130 NORTH AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 185
TABLE 131 EUROPE: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 186
TABLE 132 ASIA PACIFIC: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 186
TABLE 133 LATIN AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 187
TABLE 134 MIDDLE EAST: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 187
TABLE 135 GCC COUNTRIES: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 187
TABLE 136 NGS TECHNOLOGIES, BY COMPANY 189
TABLE 137 NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 190
TABLE 138 NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION,
2024–2031 (USD MILLION) 191
TABLE 139 NORTH AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,
BY COUNTRY, 2024–2031 (USD MILLION) 191
TABLE 140 EUROPE: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 192
TABLE 141 ASIA PACIFIC: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 192
TABLE 142 LATIN AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 193
TABLE 143 MIDDLE EAST: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,
BY REGION, 2024–2031 (USD MILLION) 193
TABLE 144 GCC COUNTRIES: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 193
TABLE 145 NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2024–2031 (USD MILLION) 195
TABLE 146 NORTH AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION) 195
TABLE 147 EUROPE: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 196
TABLE 148 ASIA PACIFIC: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 196
TABLE 149 LATIN AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 197
TABLE 150 MIDDLE EAST: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2024–2031 (USD MILLION) 197
TABLE 151 GCC COUNTRIES: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 197
TABLE 152 NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION,
2024–2031 (USD MILLION) 198
TABLE 153 NORTH AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING,
BY COUNTRY, 2024–2031 (USD MILLION) 199
TABLE 154 EUROPE: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 199
TABLE 155 ASIA PACIFIC: NGS PLATFORMS MARKET FOR SMRT SEQUENCING,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 200
TABLE 156 LATIN AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 200
TABLE 157 MIDDLE EAST: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION, 2024–2031 (USD MILLION) 201
TABLE 158 GCC COUNTRIES: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 201
TABLE 159 NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION,
2024–2031 (USD MILLION) 202
TABLE 160 NORTH AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION) 203
TABLE 161 EUROPE: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 203
TABLE 162 ASIA PACIFIC: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 204
TABLE 163 LATIN AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 204
TABLE 164 MIDDLE EAST: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2024–2031 (USD MILLION) 205
TABLE 165 GCC COUNTRIES: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 205
TABLE 166 NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION) 206
TABLE 167 NORTH AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 206
TABLE 168 EUROPE: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 207
TABLE 169 ASIA PACIFIC: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 207
TABLE 170 LATIN AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 208
TABLE 171 MIDDLE EAST: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION) 208
TABLE 172 GCC COUNTRIES: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 208
TABLE 173 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 210
TABLE 174 NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2024–2031 (USD MILLION) 211
TABLE 175 NORTH AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 211
TABLE 176 EUROPE: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 212
TABLE 177 ASIA PACIFIC: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 212
TABLE 178 LATIN AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 213
TABLE 179 MIDDLE EAST: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2024–2031 (USD MILLION) 213
TABLE 180 GCC COUNTRIES: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 213
TABLE 181 NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2024–2031 (USD MILLION) 215
TABLE 182 NORTH AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 215
TABLE 183 EUROPE: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 216
TABLE 184 ASIA PACIFIC: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 216
TABLE 185 LATIN AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 217
TABLE 186 MIDDLE EAST: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2024–2031 (USD MILLION) 217
TABLE 187 GCC COUNTRIES: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 217
TABLE 188 NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2024–2031 (USD MILLION) 219
TABLE 189 NORTH AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 219
TABLE 190 EUROPE: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 220
TABLE 191 ASIA PACIFIC: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 220
TABLE 192 LATIN AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 221
TABLE 193 MIDDLE EAST: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2024–2031 (USD MILLION) 221
TABLE 194 GCC COUNTRIES: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 221
TABLE 195 NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 223
TABLE 196 NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 224
TABLE 197 NORTH AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 224
TABLE 198 EUROPE: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 225
TABLE 199 ASIA PACIFIC: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 225
TABLE 200 LATIN AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 226
TABLE 201 MIDDLE EAST: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 226
TABLE 202 GCC COUNTRIES: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 226
TABLE 203 NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 228
TABLE 204 NORTH AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 228
TABLE 205 EUROPE: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 229
TABLE 206 ASIA PACIFIC: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 229
TABLE 207 LATIN AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 230
TABLE 208 MIDDLE EAST: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 230
TABLE 209 GCC COUNTRIES: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 230
TABLE 210 NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 231
TABLE 211 NORTH AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 232
TABLE 212 EUROPE: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 232
TABLE 213 ASIA PACIFIC: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 233
TABLE 214 LATIN AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 233
TABLE 215 MIDDLE EAST: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 233
TABLE 216 GCC COUNTRIES: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 234
TABLE 217 NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION,
2024–2031 (USD MILLION) 235
TABLE 218 NORTH AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 235
TABLE 219 EUROPE: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 236
TABLE 220 ASIA PACIFIC: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 236
TABLE 221 LATIN AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 237
TABLE 222 MIDDLE EAST: NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 237
TABLE 223 GCC COUNTRIES: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 237
TABLE 224 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 239
TABLE 225 SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 240
TABLE 226 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 240
TABLE 227 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 241
TABLE 228 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 241
TABLE 229 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 242
TABLE 230 MIDDLE EAST: SEQUENCING SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 242
TABLE 231 GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 242
TABLE 232 SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 243
TABLE 233 EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY REGION, 2024–2031 (USD MILLION) 244
TABLE 234 NORTH AMERICA: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 244
TABLE 235 EUROPE: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 245
TABLE 236 ASIA PACIFIC: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 245
TABLE 237 LATIN AMERICA: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 246
TABLE 238 MIDDLE EAST: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY REGION, 2024–2031 (USD MILLION) 246
TABLE 239 GCC COUNTRIES: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 246
TABLE 240 RNA SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 247
TABLE 241 NORTH AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 247
TABLE 242 EUROPE: RNA SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 248
TABLE 243 ASIA PACIFIC: RNA SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 248
TABLE 244 LATIN AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 249
TABLE 245 MIDDLE EAST: RNA SEQUENCING SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 249
TABLE 246 GCC COUNTRIES: RNA SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 249
TABLE 247 DE NOVO SEQUENCING SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 250
TABLE 248 NORTH AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 251
TABLE 249 EUROPE: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 251
TABLE 250 ASIA PACIFIC: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 252
TABLE 251 LATIN AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 252
TABLE 252 MIDDLE EAST: DE NOVO SEQUENCING SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 252
TABLE 253 GCC COUNTRIES: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 253
TABLE 254 CHIP SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 254
TABLE 255 NORTH AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 254
TABLE 256 EUROPE: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 255
TABLE 257 ASIA PACIFIC: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 255
TABLE 258 LATIN AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 256
TABLE 259 MIDDLE EAST: CHIP SEQUENCING SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 256
TABLE 260 GCC COUNTRIES: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 256
TABLE 261 WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 257
TABLE 262 NORTH AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 258
TABLE 263 EUROPE: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 258
TABLE 264 ASIA PACIFIC: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 259
TABLE 265 LATIN AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 259
TABLE 266 MIDDLE EAST: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 259
TABLE 267 GCC COUNTRIES: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 260
TABLE 268 METHYL SEQUENCING SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 261
TABLE 269 NORTH AMERICA: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 261
TABLE 270 EUROPE: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 262
TABLE 271 ASIA PACIFIC: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 262
TABLE 272 LATIN AMERICA: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 263
TABLE 273 MIDDLE EAST: METHYL SEQUENCING SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 263
TABLE 274 GCC COUNTRIES: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 263
TABLE 275 OTHER SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 264
TABLE 276 NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 265
TABLE 277 EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 265
TABLE 278 ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 266
TABLE 279 LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 266
TABLE 280 MIDDLE EAST: OTHER SEQUENCING SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 266
TABLE 281 GCC COUNTRIES: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 267
TABLE 282 PRESEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 267
TABLE 283 NORTH AMERICA: PRESEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 268
TABLE 284 EUROPE: PRESEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 268
TABLE 285 ASIA PACIFIC: PRESEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 269
TABLE 286 LATIN AMERICA: PRESEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 269
TABLE 287 MIDDLE EAST: PRESEQUENCING SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 269
TABLE 288 GCC COUNTRIES: PRESEQUENCING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 270
TABLE 289 PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 270
TABLE 290 LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 271
TABLE 291 NORTH AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 271
TABLE 292 EUROPE: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 272
TABLE 293 ASIA PACIFIC: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 272
TABLE 294 LATIN AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 273
TABLE 295 MIDDLE EAST: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 273
TABLE 296 GCC COUNTRIES: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 273
TABLE 297 SAMPLE PREPARATION SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 274
TABLE 298 NORTH AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 275
TABLE 299 EUROPE: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 275
TABLE 300 ASIA PACIFIC: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 276
TABLE 301 LATIN AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 276
TABLE 302 MIDDLE EAST: SAMPLE PREPARATION SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 276
TABLE 303 GCC COUNTRIES: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 277
TABLE 304 QUALITY CONTROL SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 277
TABLE 305 NORTH AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 278
TABLE 306 EUROPE: QUALITY CONTROL SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 278
TABLE 307 ASIA PACIFIC: QUALITY CONTROL SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 279
TABLE 308 LATIN AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 279
TABLE 309 MIDDLE EAST: QUALITY CONTROL SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 279
TABLE 310 GCC COUNTRIES: QUALITY CONTROL SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 280
TABLE 311 BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 281
TABLE 312 NORTH AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 281
TABLE 313 EUROPE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 282
TABLE 314 ASIA PACIFIC: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 282
TABLE 315 LATIN AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 283
TABLE 316 MIDDLE EAST: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 283
TABLE 317 GCC COUNTRIES: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 283
TABLE 318 BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 284
TABLE 319 DATA ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 285
TABLE 320 NORTH AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 285
TABLE 321 EUROPE: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 286
TABLE 322 ASIA PACIFIC: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 286
TABLE 323 LATIN AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 287
TABLE 324 MIDDLE EAST: DATA ANALYSIS SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 287
TABLE 325 GCC COUNTRIES: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 287
TABLE 326 DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 288
TABLE 327 NORTH AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 289
TABLE 328 EUROPE: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 289
TABLE 329 ASIA PACIFIC: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 290
TABLE 330 LATIN AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 290
TABLE 331 MIDDLE EAST: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 290
TABLE 332 GCC COUNTRIES: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 291
TABLE 333 DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 291
TABLE 334 NORTH AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 292
TABLE 335 EUROPE: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 292
TABLE 336 ASIA PACIFIC: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 293
TABLE 337 LATIN AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 293
TABLE 338 MIDDLE EAST: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 293
TABLE 339 GCC COUNTRIES: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 294
TABLE 340 NGS PLATFORM SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 294
TABLE 341 NORTH AMERICA: NGS PLATFORM SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 295
TABLE 342 EUROPE: NGS PLATFORM SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 295
TABLE 343 ASIA PACIFIC: NGS PLATFORM SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 296
TABLE 344 LATIN AMERICA: NGS PLATFORM SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 296
TABLE 345 MIDDLE EAST: NGS PLATFORM SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 296
TABLE 346 GCC COUNTRIES: NGS PLATFORM SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 297
TABLE 347 NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 299
TABLE 348 NGS SERVICES MARKET FOR SEQUENCING, BY REGION,
2024–2031 (USD MILLION) 300
TABLE 349 NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION) 300
TABLE 350 EUROPE: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 301
TABLE 351 ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 301
TABLE 352 LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 302
TABLE 353 MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING, BY REGION,
2024–2031 (USD MILLION) 302
TABLE 354 GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 302
TABLE 355 NGS SERVICES MARKET FOR PRESEQUENCING, BY REGION,
2024–2031 (USD MILLION) 303
TABLE 356 NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION) 304
TABLE 357 EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 304
TABLE 358 ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 305
TABLE 359 LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 305
TABLE 360 MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING, BY REGION,
2024–2031 (USD MILLION) 306
TABLE 361 GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 306
TABLE 362 NGS SERVICES MARKET FOR DATA ANALYSIS, BY REGION,
2024–2031 (USD MILLION) 307
TABLE 363 NORTH AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 307
TABLE 364 EUROPE: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY,
2024–2031 (USD MILLION) 308
TABLE 365 ASIA PACIFIC: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 308
TABLE 366 LATIN AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 309
TABLE 367 MIDDLE EAST: NGS SERVICES MARKET FOR DATA ANALYSIS, BY REGION,
2024–2031 (USD MILLION) 309
TABLE 368 GCC COUNTRIES: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 309
TABLE 369 NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 311
TABLE 370 NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 312
TABLE 371 NORTH AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 312
TABLE 372 EUROPE: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 313
TABLE 373 ASIA PACIFIC: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 313
TABLE 374 LATIN AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 314
TABLE 375 MIDDLE EAST: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 314
TABLE 376 GCC COUNTRIES: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 314
TABLE 377 NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 315
TABLE 378 NORTH AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 316
TABLE 379 EUROPE: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 316
TABLE 380 ASIA PACIFIC: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 317
TABLE 381 LATIN AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 317
TABLE 382 MIDDLE EAST: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 317
TABLE 383 GCC COUNTRIES: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 318
TABLE 384 NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 319
TABLE 385 NORTH AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 319
TABLE 386 EUROPE: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 320
TABLE 387 ASIA PACIFIC: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 320
TABLE 388 LATIN AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 321
TABLE 389 MIDDLE EAST: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 321
TABLE 390 GCC COUNTRIES: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION 2024–2031 (USD MILLION) 321
TABLE 391 NGS SERVICES MARKET FOR OTHER END USERS, BY REGION,
2024–2031 (USD MILLION) 322
TABLE 392 NORTH AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 323
TABLE 393 EUROPE: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 323
TABLE 394 ASIA PACIFIC: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 324
TABLE 395 LATIN AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 324
TABLE 396 MIDDLE EAST: NGS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 324
TABLE 397 GCC COUNTRIES: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 325
TABLE 398 NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 327
TABLE 399 NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION,
2024–2031 (USD MILLION) 328
TABLE 400 NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 328
TABLE 401 EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 329
TABLE 402 ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 329
TABLE 403 LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 330
TABLE 404 MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION,
2024–2031 (USD MILLION) 330
TABLE 405 GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 330
TABLE 406 NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 331
TABLE 407 FUNDING AND GRANTS FOR CANCER RESEARCH, BY TYPE (AS OF JANUARY 2023) 331
TABLE 408 CANCER DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 332
TABLE 409 NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 333
TABLE 410 EUROPE: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 333
TABLE 411 ASIA PACIFIC: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 334
TABLE 412 LATIN AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 334
TABLE 413 MIDDLE EAST: CANCER DIAGNOSTICS MARKET, BY REGION,
2024–2031 (USD MILLION) 334
TABLE 414 GCC COUNTRIES: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 335
TABLE 415 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION,
2024–2031 (USD MILLION) 335
TABLE 416 NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 336
TABLE 417 EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 336
TABLE 418 ASIA PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 337
TABLE 419 LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 337
TABLE 420 MIDDLE EAST: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION,
2024–2031 (USD MILLION) 337
TABLE 421 GCC COUNTRIES: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 338
TABLE 422 REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY REGION,
2024–2031 (USD MILLION) 339
TABLE 423 NORTH AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 339
TABLE 424 EUROPE: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 340
TABLE 425 ASIA PACIFIC: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 340
TABLE 426 LATIN AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 341
TABLE 427 MIDDLE EAST: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 341
TABLE 428 GCC COUNTRIES: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 341
TABLE 429 OTHER DIAGNOSTIC APPLICATIONS MARKET, BY REGION,
2024–2031 (USD MILLION) 342
TABLE 430 NORTH AMERICA: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 342
TABLE 431 EUROPE: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 343
TABLE 432 ASIA PACIFIC: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 343
TABLE 433 LATIN AMERICA: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 344
TABLE 434 MIDDLE EAST: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY REGION,
2024–2031 (USD MILLION) 344
TABLE 435 GCC COUNTRIES: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 344
TABLE 436 NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 345
TABLE 437 NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 346
TABLE 438 EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 346
TABLE 439 ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 347
TABLE 440 LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 347
TABLE 441 MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 347
TABLE 442 GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 348
TABLE 443 NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 348
TABLE 444 PHARMACOGENOMICS MARKET, BY REGION, 2024–2031 (USD MILLION) 349
TABLE 445 NORTH AMERICA: PHARMACOGENOMICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 349
TABLE 446 EUROPE: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 350
TABLE 447 ASIA PACIFIC: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 350
TABLE 448 LATIN AMERICA: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 351
TABLE 449 MIDDLE EAST: PHARMACOGENOMICS MARKET, BY REGION,
2024–2031 (USD MILLION) 351
TABLE 450 GCC COUNTRIES: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 351
TABLE 451 OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION) 352
TABLE 452 NORTH AMERICA: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 352
TABLE 453 EUROPE: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 353
TABLE 454 ASIA PACIFIC: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 353
TABLE 455 LATIN AMERICA: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 354
TABLE 456 MIDDLE EAST: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION) 354
TABLE 457 GCC COUNTRIES: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 354
TABLE 458 AGRICULTURE & ANIMAL RESEARCH MARKET, BY REGION,
2024–2031 (USD MILLION) 355
TABLE 459 NORTH AMERICA: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 356
TABLE 460 EUROPE: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 356
TABLE 461 ASIA PACIFIC: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 357
TABLE 462 LATIN AMERICA: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 357
TABLE 463 MIDDLE EAST: AGRICULTURE & ANIMAL RESEARCH MARKET, BY REGION,
2024–2031 (USD MILLION) 357
TABLE 464 GCC COUNTRIES: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 358
TABLE 465 OTHER APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION) 358
TABLE 466 NORTH AMERICA: OTHER APPLICATIONS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 359
TABLE 467 EUROPE: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 359
TABLE 468 ASIA PACIFIC: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 360
TABLE 469 LATIN AMERICA: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 360
TABLE 470 MIDDLE EAST: OTHER APPLICATIONS MARKET, BY REGION,
2024–2031 (USD MILLION) 360
TABLE 471 GCC COUNTRIES: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 361
TABLE 472 NGS MARKET, BY REGION, 2024–2031 (USD MILLION) 363
TABLE 473 NORTH AMERICA: NGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 364
TABLE 474 NORTH AMERICA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 365
TABLE 475 NORTH AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 365
TABLE 476 NORTH AMERICA: NGS CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 365
TABLE 477 NORTH AMERICA: NGS PLATFORMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 366
TABLE 478 NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 366
TABLE 479 NORTH AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 367
TABLE 480 NORTH AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 367
TABLE 481 NORTH AMERICA: NGS PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 368
TABLE 482 NORTH AMERICA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 368
TABLE 483 NORTH AMERICA: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 369
TABLE 484 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 369
TABLE 485 NORTH AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 370
TABLE 486 NORTH AMERICA: NGS SERVICES MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 370
TABLE 487 NORTH AMERICA: NGS SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 370
TABLE 488 NORTH AMERICA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 371
TABLE 489 NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 371
TABLE 490 NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 372
TABLE 491 US: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 373
TABLE 492 US: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 373
TABLE 493 US: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 373
TABLE 494 US: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 374
TABLE 495 US: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 374
TABLE 496 US: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 374
TABLE 497 US: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 375
TABLE 498 US: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 375
TABLE 499 US: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 375
TABLE 500 US: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 376
TABLE 501 US: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 376
TABLE 502 US: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 377
TABLE 503 US: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 377
TABLE 504 US: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 377
TABLE 505 US: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 378
TABLE 506 US: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 378
TABLE 507 US: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 379
TABLE 508 CANADA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 380
TABLE 509 CANADA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 380
TABLE 510 CANADA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 380
TABLE 511 CANADA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 381
TABLE 512 CANADA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 381
TABLE 513 CANADA: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 381
TABLE 514 CANADA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 382
TABLE 515 CANADA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 382
TABLE 516 CANADA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 382
TABLE 517 CANADA: PRESEQUENCING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 383
TABLE 518 CANADA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 383
TABLE 519 CANADA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 384
TABLE 520 CANADA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 384
TABLE 521 CANADA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 384
TABLE 522 CANADA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 385
TABLE 523 CANADA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 385
TABLE 524 CANADA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 386
TABLE 525 EUROPE: NGS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 386
TABLE 526 EUROPE: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 387
TABLE 527 EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 387
TABLE 528 EUROPE: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 387
TABLE 529 EUROPE: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 388
TABLE 530 EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 388
TABLE 531 EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 388
TABLE 532 EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 389
TABLE 533 EUROPE: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 389
TABLE 534 EUROPE: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 389
TABLE 535 EUROPE: PRESEQUENCING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 390
TABLE 536 EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 390
TABLE 537 EUROPE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 391
TABLE 538 EUROPE: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 391
TABLE 539 EUROPE: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 391
TABLE 540 EUROPE: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 392
TABLE 541 EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 392
TABLE 542 EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 393
TABLE 543 GERMANY: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 394
TABLE 544 GERMANY: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 394
TABLE 545 GERMANY: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 394
TABLE 546 GERMANY: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 395
TABLE 547 GERMANY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 395
TABLE 548 GERMANY: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 395
TABLE 549 GERMANY: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 396
TABLE 550 GERMANY: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 396
TABLE 551 GERMANY: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 396
TABLE 552 GERMANY: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 397
TABLE 553 GERMANY: SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 397
TABLE 554 GERMANY: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 398
TABLE 555 GERMANY: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 398
TABLE 556 GERMANY: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 398
TABLE 557 GERMANY: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 399
TABLE 558 GERMANY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 399
TABLE 559 GERMANY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 400
TABLE 560 UK: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 401
TABLE 561 UK: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 401
TABLE 562 UK: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 401
TABLE 563 UK: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 402
TABLE 564 UK: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 402
TABLE 565 UK: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 402
TABLE 566 UK: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 403
TABLE 567 UK: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 403
TABLE 568 UK: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 403
TABLE 569 UK: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 404
TABLE 570 UK: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 404
TABLE 571 UK: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 405
TABLE 572 UK: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 405
TABLE 573 UK: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 405
TABLE 574 UK: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 406
TABLE 575 UK: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 406
TABLE 576 UK: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 407
TABLE 577 FRANCE: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 408
TABLE 578 FRANCE: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 408
TABLE 579 FRANCE: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 408
TABLE 580 FRANCE: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 409
TABLE 581 FRANCE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 409
TABLE 582 FRANCE: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 409
TABLE 583 FRANCE: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 410
TABLE 584 FRANCE: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 410
TABLE 585 FRANCE: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 410
TABLE 586 FRANCE: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 411
TABLE 587 FRANCE: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 411
TABLE 588 FRANCE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 412
TABLE 589 FRANCE: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 412
TABLE 590 FRANCE: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 412
TABLE 591 FRANCE: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 413
TABLE 592 FRANCE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 413
TABLE 593 FRANCE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 414
TABLE 594 ITALY: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 415
TABLE 595 ITALY: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 415
TABLE 596 ITALY: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 415
TABLE 597 ITALY: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 416
TABLE 598 ITALY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 416
TABLE 599 ITALY: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 416
TABLE 600 ITALY: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 417
TABLE 601 ITALY: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 417
TABLE 602 ITALY: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 417
TABLE 603 ITALY: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 418
TABLE 604 ITALY: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 418
TABLE 605 ITALY: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 419
TABLE 606 ITALY: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 419
TABLE 607 ITALY: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 419
TABLE 608 ITALY: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 420
TABLE 609 ITALY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 420
TABLE 610 ITALY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 421
TABLE 611 SPAIN: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 422
TABLE 612 SPAIN: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 422
TABLE 613 SPAIN: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 422
TABLE 614 SPAIN: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 423
TABLE 615 SPAIN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 423
TABLE 616 SPAIN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 423
TABLE 617 SPAIN: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 424
TABLE 618 SPAIN: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 424
TABLE 619 SPAIN: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 424
TABLE 620 SPAIN: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 425
TABLE 621 SPAIN: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 425
TABLE 622 SPAIN: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 426
TABLE 623 SPAIN: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 426
TABLE 624 SPAIN: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 426
TABLE 625 SPAIN: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 427
TABLE 626 SPAIN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 427
TABLE 627 SPAIN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 428
TABLE 628 NETHERLANDS: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 429
TABLE 629 NETHERLANDS: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 429
TABLE 630 NETHERLANDS: NGS CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 429
TABLE 631 NETHERLANDS: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 430
TABLE 632 NETHERLANDS: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 430
TABLE 633 NETHERLANDS: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 430
TABLE 634 NETHERLANDS: NGS PRODUCTS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 431
TABLE 635 NETHERLANDS: NGS PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 431
TABLE 636 NETHERLANDS: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 431
TABLE 637 NETHERLANDS: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 432
TABLE 638 NETHERLANDS: SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 432
TABLE 639 NETHERLANDS: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 433
TABLE 640 NETHERLANDS: NGS SERVICES MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 433
TABLE 641 NETHERLANDS: NGS SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 433
TABLE 642 NETHERLANDS: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 434
TABLE 643 NETHERLANDS: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 434
TABLE 644 NETHERLANDS: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 435
TABLE 645 REST OF EUROPE: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 436
TABLE 646 REST OF EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 436
TABLE 647 REST OF EUROPE: NGS CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 436
TABLE 648 REST OF EUROPE: NGS PLATFORMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 437
TABLE 649 REST OF EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 437
TABLE 650 REST OF EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 438
TABLE 651 REST OF EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 438
TABLE 652 REST OF EUROPE: NGS PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 439
TABLE 653 REST OF EUROPE: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 439
TABLE 654 REST OF EUROPE: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 440
TABLE 655 REST OF EUROPE: SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 440
TABLE 656 REST OF EUROPE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 441
TABLE 657 REST OF EUROPE: NGS SERVICES MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 441
TABLE 658 REST OF EUROPE: NGS SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 441
TABLE 659 REST OF EUROPE: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 442
TABLE 660 REST OF EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 442
TABLE 661 REST OF EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 443
TABLE 662 ASIA PACIFIC: NGS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 444
TABLE 663 ASIA PACIFIC: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 445
TABLE 664 ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 445
TABLE 665 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 445
TABLE 666 ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 446
TABLE 667 ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 446
TABLE 668 ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 446
TABLE 669 ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 447
TABLE 670 ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 447
TABLE 671 ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 447
TABLE 672 ASIA PACIFIC: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 448
TABLE 673 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 448
TABLE 674 ASIA PACIFIC: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 449
TABLE 675 ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 449
TABLE 676 ASIA PACIFIC: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 449
TABLE 677 ASIA PACIFIC: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 450
TABLE 678 ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 450
TABLE 679 ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 451
TABLE 680 CHINA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 452
TABLE 681 CHINA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 452
TABLE 682 CHINA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 452
TABLE 683 CHINA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 453
TABLE 684 CHINA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 453
TABLE 685 CHINA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 453
TABLE 686 CHINA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 454
TABLE 687 CHINA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 454
TABLE 688 CHINA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 454
TABLE 689 CHINA: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 455
TABLE 690 CHINA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 455
TABLE 691 CHINA: FOR BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 456
TABLE 692 CHINA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 456
TABLE 693 CHINA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 456
TABLE 694 CHINA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 457
TABLE 695 CHINA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 457
TABLE 696 CHINA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 458
TABLE 697 JAPAN: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 459
TABLE 698 JAPAN: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 459
TABLE 699 JAPAN: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 459
TABLE 700 JAPAN: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 460
TABLE 701 JAPAN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 460
TABLE 702 JAPAN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 460
TABLE 703 JAPAN: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 461
TABLE 704 JAPAN: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 461
TABLE 705 JAPAN: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 461
TABLE 706 JAPAN: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 462
TABLE 707 JAPAN: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 462
TABLE 708 JAPAN: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 463
TABLE 709 JAPAN: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 463
TABLE 710 JAPAN: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 463
TABLE 711 JAPAN: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 464
TABLE 712 JAPAN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 464
TABLE 713 JAPAN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 465
TABLE 714 INDIA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 466
TABLE 715 INDIA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 466
TABLE 716 INDIA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 466
TABLE 717 INDIA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 467
TABLE 718 INDIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 467
TABLE 719 INDIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 467
TABLE 720 INDIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 468
TABLE 721 INDIA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 468
TABLE 722 INDIA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 468
TABLE 723 INDIA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 469
TABLE 724 INDIA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 469
TABLE 725 INDIA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 470
TABLE 726 INDIA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 470
TABLE 727 INDIA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 470
TABLE 728 INDIA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 471
TABLE 729 INDIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 471
TABLE 730 INDIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 472
TABLE 731 AUSTRALIA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 472
TABLE 732 AUSTRALIA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 473
TABLE 733 AUSTRALIA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 473
TABLE 734 AUSTRALIA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 473
TABLE 735 AUSTRALIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 474
TABLE 736 AUSTRALIA: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 474
TABLE 737 AUSTRALIA: NGS PRODUCTS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 474
TABLE 738 AUSTRALIA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 475
TABLE 739 AUSTRALIA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 475
TABLE 740 AUSTRALIA: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 476
TABLE 741 AUSTRALIA: SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 476
TABLE 742 AUSTRALIA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 477
TABLE 743 AUSTRALIA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 477
TABLE 744 AUSTRALIA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 477
TABLE 745 AUSTRALIA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 478
TABLE 746 AUSTRALIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 478
TABLE 747 AUSTRALIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 479
TABLE 748 SOUTH KOREA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 480
TABLE 749 SOUTH KOREA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 480
TABLE 750 SOUTH KOREA: NGS CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 480
TABLE 751 SOUTH KOREA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 481
TABLE 752 SOUTH KOREA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 481
TABLE 753 SOUTH KOREA: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 481
TABLE 754 SOUTH KOREA: NGS PRODUCTS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 482
TABLE 755 SOUTH KOREA: NGS PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 482
TABLE 756 SOUTH KOREA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 482
TABLE 757 SOUTH KOREA: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 483
TABLE 758 SOUTH KOREA: SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 483
TABLE 759 SOUTH KOREA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 484
TABLE 760 SOUTH KOREA: NGS SERVICES MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 484
TABLE 761 SOUTH KOREA: NGS SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 484
TABLE 762 SOUTH KOREA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 485
TABLE 763 SOUTH KOREA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 485
TABLE 764 SOUTH KOREA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 486
TABLE 765 REST OF ASIA PACIFIC: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 487
TABLE 766 REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 487
TABLE 767 REST OF ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 487
TABLE 768 REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 488
TABLE 769 REST OF ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 488
TABLE 770 REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 488
TABLE 771 REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 489
TABLE 772 REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 489
TABLE 773 REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 490
TABLE 774 REST OF ASIA PACIFIC: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 490
TABLE 775 REST OF ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 491
TABLE 776 REST OF ASIA PACIFIC: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 491
TABLE 777 REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 492
TABLE 778 REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 492
TABLE 779 REST OF ASIA PACIFIC: NGS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 493
TABLE 780 REST OF ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 493
TABLE 781 REST OF ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 494
TABLE 782 LATIN AMERICA: NGS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 494
TABLE 783 LATIN AMERICA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 495
TABLE 784 LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 495
TABLE 785 LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 495
TABLE 786 LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 496
TABLE 787 LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 496
TABLE 788 LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 496
TABLE 789 LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 497
TABLE 790 LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 497
TABLE 791 LATIN AMERICA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 497
TABLE 792 LATIN AMERICA: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 498
TABLE 793 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 498
TABLE 794 LATIN AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 499
TABLE 795 LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 499
TABLE 796 LATIN AMERICA: NGS SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 499
TABLE 797 LATIN AMERICA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 500
TABLE 798 LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 500
TABLE 799 LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 501
TABLE 800 BRAZIL: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 501
TABLE 801 BRAZIL: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 502
TABLE 802 BRAZIL: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 502
TABLE 803 BRAZIL: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 502
TABLE 804 BRAZIL: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 503
TABLE 805 BRAZIL: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 503
TABLE 806 BRAZIL: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 503
TABLE 807 BRAZIL: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 504
TABLE 808 BRAZIL: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 504
TABLE 809 BRAZIL: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 504
TABLE 810 BRAZIL: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 505
TABLE 811 BRAZIL: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 505
TABLE 812 BRAZIL: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 506
TABLE 813 BRAZIL: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 506
TABLE 814 BRAZIL: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 506
TABLE 815 BRAZIL: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 507
TABLE 816 BRAZIL: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 507
TABLE 817 MEXICO: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 508
TABLE 818 MEXICO: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 508
TABLE 819 MEXICO: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 509
TABLE 820 MEXICO: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 509
TABLE 821 MEXICO: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 509
TABLE 822 MEXICO: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 510
TABLE 823 MEXICO: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 510
TABLE 824 MEXICO: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 510
TABLE 825 MEXICO: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 511
TABLE 826 MEXICO: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 511
TABLE 827 MEXICO: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 512
TABLE 828 MEXICO: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 512
TABLE 829 MEXICO: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 513
TABLE 830 MEXICO: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 513
TABLE 831 MEXICO: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 513
TABLE 832 MEXICO: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 514
TABLE 833 MEXICO: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 514
TABLE 834 REST OF LATIN AMERICA: NGS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 515
TABLE 835 REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 515
TABLE 836 REST OF LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 516
TABLE 837 REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 516
TABLE 838 REST OF LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 516
TABLE 839 REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 517
TABLE 840 REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 517
TABLE 841 REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 518
TABLE 842 REST OF LATIN AMERICA: NGS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 518
TABLE 843 REST OF LATIN AMERICA: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 519
TABLE 844 REST OF LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 519
TABLE 845 REST OF LATIN AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 520
TABLE 846 REST OF LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 520
TABLE 847 REST OF LATIN AMERICA: NGS SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 520
TABLE 848 REST OF LATIN AMERICA: NGS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 521
TABLE 849 REST OF LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 521
TABLE 850 REST OF LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 522
TABLE 851 MIDDLE EAST: NGS MARKET, BY REGION, 2024–2031 (USD MILLION) 522
TABLE 852 MIDDLE EAST: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 522
TABLE 853 MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 523
TABLE 854 MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 523
TABLE 855 MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 523
TABLE 856 MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 524
TABLE 857 MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 524
TABLE 858 MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 524
TABLE 859 MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 525
TABLE 860 MIDDLE EAST: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 525
TABLE 861 MIDDLE EAST: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 526
TABLE 862 MIDDLE EAST: SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 526
TABLE 863 MIDDLE EAST: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 527
TABLE 864 MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 527
TABLE 865 MIDDLE EAST: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 527
TABLE 866 MIDDLE EAST: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 528
TABLE 867 MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 528
TABLE 868 MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 529
TABLE 869 GCC COUNTRIES: NGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 529
TABLE 870 GCC COUNTRIES: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 529
TABLE 871 GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 530
TABLE 872 GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 530
TABLE 873 GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 530
TABLE 874 GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 531
TABLE 875 GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 531
TABLE 876 GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 532
TABLE 877 GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 532
TABLE 878 GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 532
TABLE 879 GCC COUNTRIES: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 533
TABLE 880 GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 533
TABLE 881 GCC COUNTRIES: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 534
TABLE 882 GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 534
TABLE 883 GCC COUNTRIES: NGS SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 534
TABLE 884 GCC COUNTRIES: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 535
TABLE 885 GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 535
TABLE 886 GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 536
TABLE 887 SAUDI ARABIA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 537
TABLE 888 SAUDI ARABIA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 537
TABLE 889 SAUDI ARABIA: NGS CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 537
TABLE 890 SAUDI ARABIA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 538
TABLE 891 SAUDI ARABIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 538
TABLE 892 SAUDI ARABIA: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 538
TABLE 893 SAUDI ARABIA: NGS PRODUCTS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 539
TABLE 894 SAUDI ARABIA: NGS PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 539
TABLE 895 SAUDI ARABIA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 539
TABLE 896 SAUDI ARABIA: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 540
TABLE 897 SAUDI ARABIA: SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 540
TABLE 898 SAUDI ARABIA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 541
TABLE 899 SAUDI ARABIA: NGS SERVICES MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 541
TABLE 900 SAUDI ARABIA: NGS SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 541
TABLE 901 SAUDI ARABIA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 542
TABLE 902 SAUDI ARABIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 542
TABLE 903 SAUDI ARABIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 543
TABLE 904 UAE: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 543
TABLE 905 UAE: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 544
TABLE 906 UAE: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 544
TABLE 907 UAE: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 544
TABLE 908 UAE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 545
TABLE 909 UAE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 545
TABLE 910 UAE: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 545
TABLE 911 UAE: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 546
TABLE 912 UAE: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 546
TABLE 913 UAE: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 546
TABLE 914 UAE: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 547
TABLE 915 UAE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 547
TABLE 916 UAE: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 548
TABLE 917 UAE: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 548
TABLE 918 UAE: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 548
TABLE 919 UAE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 549
TABLE 920 UAE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 549
TABLE 921 REST OF GCC COUNTRIES: NGS MARKET, BY OFFERING,
2024–2031 (USD MILLION) 550
TABLE 922 REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 550
TABLE 923 REST OF GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 551
TABLE 924 REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 551
TABLE 925 REST OF GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 551
TABLE 926 REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 552
TABLE 927 REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 552
TABLE 928 REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 553
TABLE 929 REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 553
TABLE 930 REST OF GCC COUNTRIES: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 554
TABLE 931 REST OF GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 554
TABLE 932 REST OF GCC COUNTRIES: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 555
TABLE 933 REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 555
TABLE 934 REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 555
TABLE 935 REST OF GCC COUNTRIES: NGS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 556
TABLE 936 REST OF GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 556
TABLE 937 REST OF GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 557
TABLE 938 REST OF MIDDLE EAST: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 558
TABLE 939 REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 558
TABLE 940 REST OF MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 558
TABLE 941 REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 559
TABLE 942 REST OF MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 559
TABLE 943 REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 560
TABLE 944 REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 560
TABLE 945 REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 561
TABLE 946 REST OF MIDDLE EAST: NGS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 561
TABLE 947 REST OF MIDDLE EAST: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 562
TABLE 948 REST OF MIDDLE EAST: SEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 562
TABLE 949 REST OF MIDDLE EAST: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 563
TABLE 950 REST OF MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 563
TABLE 951 REST OF MIDDLE EAST: NGS SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 564
TABLE 952 REST OF MIDDLE EAST: NGS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 564
TABLE 953 REST OF MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 565
TABLE 954 REST OF MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 565
TABLE 955 AFRICA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 566
TABLE 956 AFRICA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 566
TABLE 957 AFRICA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 567
TABLE 958 AFRICA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 567
TABLE 959 AFRICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE,
2024–2031 (USD MILLION) 567
TABLE 960 AFRICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 568
TABLE 961 AFRICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 568
TABLE 962 AFRICA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 569
TABLE 963 AFRICA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 569
TABLE 964 AFRICA: PRESEQUENCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 570
TABLE 965 AFRICA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 570
TABLE 966 AFRICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 571
TABLE 967 AFRICA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 571
TABLE 968 AFRICA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 571
TABLE 969 AFRICA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 572
TABLE 970 AFRICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2024–2031 (USD MILLION) 572
TABLE 971 AFRICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 573
TABLE 972 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS,
JANUARY 2023–JANUARY 2026 574
TABLE 973 NGS MARKET: DEGREE OF COMPETITION 578
TABLE 974 NGS MARKET: REGION FOOTPRINT 584
TABLE 975 NGS MARKET: OFFERING FOOTPRINT 585
TABLE 976 NGS MARKET: APPLICATION FOOTPRINT 586
TABLE 977 NGS PLATFORMS MARKET: TECHNOLOGY FOOTPRINT 587
TABLE 978 NGS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 590
TABLE 979 NGS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 591
TABLE 980 NGS MARKET: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 593
TABLE 981 NGS MARKET: DEALS, JANUARY 2023–JANUARY 2026 594
TABLE 982 NGS MARKET: EXPANSIONS, JANUARY 2023–JANUARY 2026 595
TABLE 983 ILLUMINA, INC.: COMPANY OVERVIEW 596
TABLE 984 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED 597
TABLE 985 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 600
TABLE 986 ILLUMINA, INC.: DEALS, JANUARY 2023–JANUARY 2026 601
TABLE 987 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 603
TABLE 988 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 604
TABLE 989 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES,
JANUARY 2023–JANUARY 2026 607
TABLE 990 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–JANUARY 2026 608
TABLE 991 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–JANUARY 2026 609
TABLE 992 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 610
TABLE 993 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 611
TABLE 994 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES,
JANUARY 2023–JANUARY 2026 613
TABLE 995 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–JANUARY 2026 613
TABLE 996 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2023–JANUARY 2026 614
TABLE 997 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 615
TABLE 998 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED 616
TABLE 999 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES,
JANUARY 2023–JANUARY 2026 618
TABLE 1000 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2023–JANUARY 2026 618
TABLE 1001 F. HOFFMANN-LA ROCHE LTD.: OTHER DEVELOPMENTS,
JANUARY 2023–JANUARY 2026 619
TABLE 1002 QIAGEN: COMPANY OVERVIEW 620
TABLE 1003 QIAGEN: PRODUCTS/SERVICES OFFERED 621
TABLE 1004 QIAGEN: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 623
TABLE 1005 QIAGEN: DEALS, JANUARY 2023–JANUARY 2026 624
TABLE 1006 QIAGEN: EXPANSIONS, JANUARY 2023–JANUARY 2026 625
TABLE 1007 DANAHER CORPORATION: COMPANY OVERVIEW 627
TABLE 1008 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 628
TABLE 1009 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 630
TABLE 1010 DANAHER CORPORATION: DEALS, JANUARY 2023–JANUARY 2026 631
TABLE 1011 DANAHER CORPORATION: EXPANSIONS, JANUARY 2023–JANUARY 2026 631
TABLE 1012 REVVITY: COMPANY OVERVIEW 632
TABLE 1013 REVVITY: PRODUCTS/SERVICES OFFERED 633
TABLE 1014 REVVITY: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 635
TABLE 1015 REVVITY: DEALS, JANUARY 2023–JANUARY 2026 635
TABLE 1016 REVVITY: EXPANSIONS, JANUARY 2023–JANUARY 2026 636
TABLE 1017 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 637
TABLE 1018 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED 638
TABLE 1019 EUROFINS SCIENTIFIC: DEALS, JANUARY 2023–JANUARY 2026 638
TABLE 1020 PACBIO: COMPANY OVERVIEW 639
TABLE 1021 PACBIO: PRODUCTS/SERVICES OFFERED 640
TABLE 1022 PACBIO: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 643
TABLE 1023 PACBIO: DEALS, JANUARY 2023–JANUARY 2026 643
TABLE 1024 PACBIO: EXPANSIONS, JANUARY 2023–JANUARY 2026 644
TABLE 1025 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW 645
TABLE 1026 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS/SERVICES OFFERED 646
TABLE 1027 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2023–JANUARY 2026 648
TABLE 1028 OXFORD NANOPORE TECHNOLOGIES PLC: EXPANSIONS,
JANUARY 2023-JANUARY 2026 649
TABLE 1029 TAKARA BIO INC.: COMPANY OVERVIEW 650
TABLE 1030 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED 651
TABLE 1031 TAKARA BIO INC.: DEALS, JANUARY 2023–JANUARY 2026 653
TABLE 1032 BGI GROUP: COMPANY OVERVIEW 654
TABLE 1033 BGI GROUP: PRODUCTS/SERVICES OFFERED 654
TABLE 1034 BD: COMPANY OVERVIEW 658
TABLE 1035 BD: PRODUCTS/SERVICES OFFERED 659
TABLE 1036 BD: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 660
TABLE 1037 10X GENOMICS: COMPANY OVERVIEW 661
TABLE 1038 10X GENOMICS: PRODUCTS/SERVICES OFFERED 662
TABLE 1039 PROMEGA CORPORATION: COMPANY OVERVIEW 665
TABLE 1040 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED 665
TABLE 1041 LGC LIMITED: COMPANY OVERVIEW 666
TABLE 1042 LGC LIMITED: PRODUCTS/SERVICES OFFERED 667
TABLE 1043 LGC LIMITED: DEALS, JANUARY 2023–JANUARY 2026 668
TABLE 1044 WUXI BIOLOGICS: COMPANY OVERVIEW 669
TABLE 1045 WUXI BIOLOGICS: PRODUCTS/SERVICES OFFERED 670
TABLE 1046 TECAN TRADING AG: COMPANY OVERVIEW 671
TABLE 1047 TECAN TRADING AG: PRODUCTS/SERVICES OFFERED 672
TABLE 1048 TECAN TRADING AG: DEALS, JANUARY 2023–JANUARY 2026 673
TABLE 1049 TWIST BIOSCIENCE: COMPANY OVERVIEW 674
TABLE 1050 TWIST BIOSCIENCE: PRODUCTS/SERVICES OFFERED 675
TABLE 1051 TWIST BIOSCIENCE: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 676
TABLE 1052 TWIST BIOSCIENCE: DEALS, JANUARY 2023–JANUARY 2026 677
TABLE 1053 AZENTA US INC.: COMPANY OVERVIEW 678
TABLE 1054 AZENTA US INC.: PRODUCTS/SERVICES OFFERED 679
TABLE 1055 AZENTA US INC.: DEALS, JANUARY 2023–JANUARY 2026 680
TABLE 1056 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 702
TABLE 1057 RISK ASSESSMENT 704

LIST OF FIGURES

FIGURE 1 NEXT-GENERATION SEQUENCING MARKET SEGMENTATION AND REGIONAL SCOPE 59
FIGURE 2 NEXT-GENERATION SEQUENCING MARKET: YEARS CONSIDERED 61
FIGURE 3 MARKET SCENARIO 63
FIGURE 4 GLOBAL NEXT-GENERATION SEQUENCING MARKET, 2024–2031 64
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NEXT-GENERATION SEQUENCING MARKET 64
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF NEXT-GENERATION SEQUENCING MARKET 65
FIGURE 7 HIGH-GROWTH SEGMENTS IN NEXT-GENERATION SEQUENCING MARKET 66
FIGURE 8 ASIA PACIFIC TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD 67
FIGURE 9 ADVANCEMENTS IN SEQUENCING PLATFORMS TO DRIVE MARKET GROWTH 68
FIGURE 10 PRODUCTS OFFERING AND US LED NORTH AMERICA’S NEXT-GENERATION SEQUENCING MARKET IN 2025 69
FIGURE 11 CHINA TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD 70
FIGURE 12 PRODUCTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 70
FIGURE 13 NEXT-GENERATION SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 71
FIGURE 14 NEXT-GENERATION SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS 79
FIGURE 15 GROWTH OF GLOBAL GDP, 2020–2024 81
FIGURE 16 VALUE CHAIN ANALYSIS 82
FIGURE 17 NEXT-GENERATION SEQUENCING MARKET: ECOSYSTEM ANALYSIS 84
FIGURE 18 AVERAGE SELLING PRICE OF PLATFORMS, BY KEY PLAYER, 2025 (USD) 87
FIGURE 19 AVERAGE SELLING PRICE OF CONSUMABLES, BY KEY PLAYER, 2025 (USD) 88
FIGURE 20 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2025 (USD) 89
FIGURE 21 AVERAGE SELLING PRICE, BY REGION, 2025 (USD) 90
FIGURE 22 NEXT-GENERATION SEQUENCING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 100
FIGURE 23 INVESTMENT & FUNDING SCENARIO, 2023–2025 (USD MILLION) 101
FIGURE 24 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 107
FIGURE 25 KEY BUYING CRITERIA FOR NGS PRODUCTS, BY END USER 108
FIGURE 26 PATENT APPLICATIONS IN NEXT-GENERATION SEQUENCING MARKET, JANUARY 2015–DECEMBER 2025 124
FIGURE 27 IMPACT OF AI/GEN AI ON NEXT-GENERATION SEQUENCING MARKET 127
FIGURE 28 NOVASEQ SERIES (X/X PLUS) PLATFORM SHIPMENTS, 2023–2025 (UNITS) 162
FIGURE 29 MISEQ/MISEQ I100 PLATFORM SHIPMENTS, 2023–2025 (UNITS) 163
FIGURE 30 NEXTSEQ 1K/2K AND 550 PLATFORM SHIPMENTS, 2023–2025 (UNITS) 164
FIGURE 31 NOVASEQ 6000 PLATFORM SHIPMENTS, 2023–2025 (UNITS) 165
FIGURE 32 REVIO PLATFORM REVENUE, 2023–2025 (USD MILLION) 167
FIGURE 33 REVIO PLATFORM SHIPMENTS, 2023–2025 (UNITS) 167
FIGURE 34 SEQUEL II/IIE PLATFORM REVENUE, 2023–2025 (USD MILLION) 168
FIGURE 35 SEQUEL II/IIE PLATFORM SHIPMENTS, 2023–2025 (UNITS) 168
FIGURE 36 VEGA SEQ PLATFORM REVENUE, 2023–2025 (USD MILLION) 169
FIGURE 37 VEGA SEQ PLATFORM SHIPMENTS, 2023–2025 (UNITS) 169
FIGURE 38 NORTH AMERICA: NGS MARKET SNAPSHOT 364
FIGURE 39 ASIA PACIFIC: NGS MARKET SNAPSHOT 444
FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS, 2021–2025 (USD BILLION) 576
FIGURE 41 MARKET SHARE ANALYSIS, 2025 577
FIGURE 42 NGS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 580
FIGURE 43 NGS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 582
FIGURE 44 NGS MARKET: COMPANY FOOTPRINT 583
FIGURE 45 NGS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 589
FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN, AND 5-YEAR STOCK BETA
OF KEY VENDORS 592
FIGURE 47 EV/EBITDA OF KEY VENDORS 592
FIGURE 48 ILLUMINA, INC.: COMPANY SNAPSHOT (2025) 597
FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 604
FIGURE 50 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 611
FIGURE 51 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025) 616
FIGURE 52 QIAGEN: COMPANY SNAPSHOT (2025) 621
FIGURE 53 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 628
FIGURE 54 REVVITY: COMPANY SNAPSHOT (2025) 632
FIGURE 55 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024) 637
FIGURE 56 PACBIO: COMPANY SNAPSHOT (2025) 640
FIGURE 57 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2024) 646
FIGURE 58 TAKARA BIO INC.: COMPANY SNAPSHOT (2024) 651
FIGURE 59 BD: COMPANY SNAPSHOT (2025) 659
FIGURE 60 10X GENOMICS: COMPANY SNAPSHOT (2025) 662
FIGURE 61 LGC LIMITED: COMPANY SNAPSHOT (2024) 667
FIGURE 62 WUXI BIOLOGICS: COMPANY SNAPSHOT (2024) 670
FIGURE 63 TECAN TRADING AG: COMPANY SNAPSHOT (2024) 672
FIGURE 64 TWIST BIOSCIENCE: COMPANY SNAPSHOT (2025) 675
FIGURE 65 AZENTA US INC.: COMPANY SNAPSHOT (2025) 679
FIGURE 66 NEXT-GENERATION SEQUENCING MARKET: RESEARCH DESIGN 691
FIGURE 67 NEXT-GENERATION SEQUENCING MARKET: BREAKDOWN OF PRIMARIES 693
FIGURE 68 NEXT-GENERATION SEQUENCING MARKET: INSIGHTS FROM PRIMARIES 694
FIGURE 69 GLOBAL NEXT-GENERATION SEQUENCING MARKET ESTIMATION, 2025 695
FIGURE 70 NEXT-GENERATION SEQUENCING MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH), 2025 696
FIGURE 71 ILLUSTRATIVE EXAMPLE OF ILLUMINA, INC.: REVENUE ANALYSIS, 2025 696
FIGURE 72 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 697
FIGURE 73 NEXT-GENERATION SEQUENCING MARKET: CAGR PROJECTIONS 700
FIGURE 74 NEXT-GENERATION SEQUENCING MARKET: DATA TRIANGULATION 701

指向性エネルギー兵器（DEW）市場規模、シェア、動向、2035年までの世界予測前の記事ソリッドステート変圧器（SST）市場規模、シェア、動向、2035年までの世界予測次の記事

次世代シーケンシング市場規模、シェア、動向、2030年までの世界予測

Report Description

List of Companies Profiled in the Report:

Research Coverage:

Key Benefits of Buying the Report:

The report provides insights into the following points:

Table of Contents

LIST OF TABLES

LIST OF FIGURES

お問合せフォーム

Report Description

List of Companies Profiled in the Report:

Research Coverage:

Key Benefits of Buying the Report:

The report provides insights into the following points:

Table of Contents

LIST OF TABLES

LIST OF FIGURES

お問合せフォーム

関連記事

オルガノイド研究

シングルセルシーケンシング市場 – 2030年までの世界予測

ニューロモジュレーション市場規模、シェア、動向、2030年までの世界予測